Literature DB >> 22287285

Efficient derivation of human embryonic stem cell lines from discarded embryos through increases in the concentration of basic fibroblast growth factor.

Yanwei Wang1, Chenming Xu, Haiyan Wang, Juan Liu, Shi Hui, Ning Li, Fujun Liu, Jianyuan Li.   

Abstract

We describe the derivation and characterization of three novel human embryonic stem (hES) cell lines (YT1, YT2, YT3). One hES line (YT1) was obtained from six discarded blastocysts in a culture medium supplemented with 12 ng/ml basic fibroblast growth factor (bFGF), and two lines (YT2,YT3)were obtained from three discarded blastocysts in the same medium but supplemented with 16 ng/ml bFGF. These cell lines were derived by partial or whole embryo culture followed by further expansion after manual dissection of the passaged cells. These cells were passaged continuously for more than 6 or 8 months and possessed all of the typical features of pluripotent hES cell lines, such as typical morphological characteristics and the expression of hES-specific markers (TRA-1-60, TRA-1-81, SSEA-4, SSEA-3, alkaline phosphatase, Oct4, Nanog) and pluripotency-related genes (Oct4, Nanog, TDGF1, Sox2, EBAF, Thy-1, FGF4, Rex1). The lines maintained normal karyotypes after long-term cultivation. The karyotype of YT1 and YT3 was 46,XX, and that of YT2 was 46, XY. Pluripotency was confirmed by in vitro and in vivo differentiation, and genetic identity was demonstrated by DNA fingerprinting.Our results indicate that higher concentrations of bFGF at the early culture stage support efficient the hES cell derivation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287285     DOI: 10.1007/s13577-011-0039-7

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  20 in total

1.  Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells.

Authors:  Jonathan S Draper; Kath Smith; Paul Gokhale; Harry D Moore; Edna Maltby; Julie Johnson; Lorraine Meisner; Thomas P Zwaka; James A Thomson; Peter W Andrews
Journal:  Nat Biotechnol       Date:  2003-12-07       Impact factor: 54.908

2.  Derivation, characterization, and differentiation of human embryonic stem cells.

Authors:  Nico Heins; Mikael C O Englund; Cecilia Sjöblom; Ulf Dahl; Anna Tonning; Christina Bergh; Anders Lindahl; Charles Hanson; Henrik Semb
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  Preserving the genetic integrity of human embryonic stem cells.

Authors:  Maisam M Mitalipova; Raj R Rao; Deborah M Hoyer; Julie A Johnson; Lorraine F Meisner; Karen L Jones; Stephen Dalton; Steven L Stice
Journal:  Nat Biotechnol       Date:  2005-01       Impact factor: 54.908

4.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.

Authors:  B E Reubinoff; M F Pera; C Y Fong; A Trounson; A Bongso
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

5.  Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site.

Authors:  M J Cooke; M Stojkovic; S A Przyborski
Journal:  Stem Cells Dev       Date:  2006-04       Impact factor: 3.272

6.  Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells.

Authors:  Ren-He Xu; Ruthann M Peck; Dong S Li; Xuezhu Feng; Tenneille Ludwig; James A Thomson
Journal:  Nat Methods       Date:  2005-02-17       Impact factor: 28.547

7.  Derivation of human embryonic stem cells in defined conditions.

Authors:  Tenneille E Ludwig; Mark E Levenstein; Jeffrey M Jones; W Travis Berggren; Erika R Mitchen; Jennifer L Frane; Leann J Crandall; Christine A Daigh; Kevin R Conard; Marian S Piekarczyk; Rachel A Llanas; James A Thomson
Journal:  Nat Biotechnol       Date:  2006-01-01       Impact factor: 54.908

8.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  Derivation of two new human embryonic stem cell lines from nonviable human embryos.

Authors:  Svetlana Gavrilov; Darja Marolt; Nataki C Douglas; Robert W Prosser; Imran Khalid; Mark V Sauer; Donald W Landry; Gordana Vunjak-Novakovic; Virginia E Papaioannou
Journal:  Stem Cells Int       Date:  2011-05-22       Impact factor: 5.443

10.  Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture.

Authors:  Miodrag Stojkovic; Majlinda Lako; Petra Stojkovic; Rebecca Stewart; Stefan Przyborski; Lyle Armstrong; Jerry Evans; Mary Herbert; Louise Hyslop; Sajjad Ahmad; Alison Murdoch; Tom Strachan
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

View more
  4 in total

1.  Enrichment of skin-derived neural precursor cells from dermal cell populations by altering culture conditions.

Authors:  Vahid Bayati; Rohoullah Gazor; Reza Nejatbakhsh; Fereshteh Negad Dehbashi
Journal:  Stem Cell Investig       Date:  2016-11-23

2.  Effects of epidermal growth factor and basic fibroblast growth factor on the proliferation and osteogenic and neural differentiation of adipose-derived stem cells.

Authors:  Feihu Hu; Xiu Wang; Gaofeng Liang; Lanxin Lv; Yanliang Zhu; Bo Sun; Zhongdang Xiao
Journal:  Cell Reprogram       Date:  2013-06       Impact factor: 1.987

3.  MiR-218 Induces Neuronal Differentiation of ASCs in a Temporally Sequential Manner with Fibroblast Growth Factor by Regulation of the Wnt Signaling Pathway.

Authors:  Feihu Hu; Bo Sun; Peng Xu; Yanliang Zhu; Xian-Hui Meng; Gao-Jun Teng; Zhong-Dang Xiao
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

4.  Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.

Authors:  Xiu-feng Hua; Yan-wei Wang; Yu-xiao Tang; Sheng-qiang Yu; Shao-hua Jin; Xiao-mei Meng; Hua-feng Li; Fu-jun Liu; Qiang Sun; Hai-yan Wang; Jian-yuan Li
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.